Results of the SAFE-TAVI Clinical Study, addressing aortic stenosis, will be presented at the Transcatheter Cardiovascular Therapeutics Conference (TCT), TCT 2023, to be held October 23-26 in San Francisco, CA, according to OpSens, a Quebec-based medical device company.